Webinar: OncoBEAM ctDNA Testing

Date: 2019/05/08

Location: Online-Webinar

Country: EMEA

Please register here

Early Response Prediction and Therapy Surveillance in Melanoma and Pancreatic Cancer

Join the one hour webinar on May 8th , 2019  5:00 PM (German time)/ 11:00 AM (EDT)/ 8:00 AM (PDT)


  • Evan J. Lipson, MD, Medical Oncologist, John Hopkins Kimmel Cancer Center
  • Stefan Holdenrieder, Prof., Director of the Institute of Laboratory Medicine, German Heart Center of the Technical University, Munich


  • Influence of circulating tumor DNA (ctDNA) testing to patient management (patient care decisions, alter radiographic interpretions, impact clinical outcome)
  • Value of ctDNA measurement next to radiographic imaging in advanced melanoma patients receiving immunotherapy - implications for clinical management and better resolution of tumor activity
  • Potential clinical benefits of monitoring changes in ctDNA levels (early response prediction and treatment monitoring) in pancreatic cancer patients during chemotherapy

Tags: Events, Cancer relevance, Pancreatic cancer, Melanoma

Back to list